Nicety Pharmaceutical Private Limited
About Nicety Pharmaceutical Private Limited
Data last updated:
Nicety Pharmaceutical Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 November 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24304DL2019PTC357787. Its GSTIN is 10AAGCN7639F1ZL (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹4 Lakh. It is led by directors Shashank and Rajesh Kumar Singh.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No – B 784/1 Floor Ground Land Mark Near Vaishno Devi Mandir Inder Enclave, New Delhi, Delhi, India – 110081.
As per the financials filed for FY 2025, the company reported a revenue of ₹17.72 Lakh, a decline of 11% compared to the previous year. For the same year it recorded a net profit of ₹26,504 (net margin 1.5%) and EBITDA of ₹56,213 (EBITDA margin 3.2%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 35% over five years.
Company details
Contact details
Nicety Pharmaceutical Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No – B 784/1 Floor Ground Land Mark Near Vaishno Devi Mandir Inder Enclave, New Delhi, Delhi, India – 110081
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Nicety Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Nicety Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Nicety Pharmaceutical Private Limited, buy the company report.
Financials of Nicety Pharmaceutical Private Limited
FY 2025 filings availableNicety Pharmaceutical Private Limited reported revenue of ₹17.72 Lakh (down 11% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 11% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 35%. EBITDA fell 37% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹56,213 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹26,504 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.2% | ||||
| Net Profit Margin | 1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nicety Pharmaceutical Private Limited, buy the company report.
Board of directors of Nicety Pharmaceutical Private Limited
Nicety Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shashank Also directs: Pristine Lifesciences Private Limited | Director | 20 Nov 2019 | 6 Years 11 Months | Current |
| Rajesh Kumar Singh | Director | 20 Nov 2019 | 6 Years 11 Months | Current |
Peer comparison
Nicety Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kmcure Pharmaceuticals Private Limited | ₹17.72 Lakh (FY 2025) | -32.0% | Patna, Bihar, India | |||
| Namokar Vintrade Private Limited | ₹17.72 Lakh (FY 2025) | 53.0% | Kolkata, West Bengal, India | |||
| Phlagon Industries Private Limited | ₹17.72 Lakh (FY 2024) | 309.0% | Baraut, Uttar Pradesh, India | |||
| Satyabhog Industries (OPC) Private Limited | ₹17.72 Lakh (FY 2022) | -79.0% | Jabalpur, Madhya Pradesh, India | |||
| Pollen Tea Plantation Private Limited | ₹17.72 Lakh (FY 2025) | 0.0% | Kolkata, West Bengal, India | |||
| Nicety Pharmaceutical Private Limitedthis company | ₹17.72 Lakh (FY 2025) | ₹26,504 | 1.5% | -11.0% | New Delhi, Delhi, India | |
| Momnext Pharma Private Limited | ₹17.72 Lakh (FY 2024) | -25.0% | Noida, Uttar Pradesh, India | |||
| Yuvin Industries Private Limited | ₹17.71 Lakh (FY 2025) | -55.0% | New Delhi, Delhi, India | |||
| Dhatrigram Handloom Producer Company Limited | ₹17.71 Lakh (FY 2024) | -8.0% | Kalna, West Bengal, India | |||
| Bio World Natural Farm Private Limited | ₹17.71 Lakh (FY 2024) | 84.0% | Raikot, Punjab, India | |||
| Infinictum Lifesciences Private Limited | ₹17.71 Lakh (FY 2025) | 0.0% | Aurangabad, Maharashtra, India |
To see the full peer comparison of Nicety Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Nicety Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nicety Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nicety Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAGCN7639F1ZL | Bihar | Active | 01 Feb 2020 |
To see the full GST registrations and return filing status of Nicety Pharmaceutical Private Limited, buy the company report.
Recent activity
Nicety Pharmaceutical Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Navnitkumar Ramdevnarayan Sinha ceased to be Director on 28 Sep 2023.
Frequently asked questions
Nicety Pharmaceutical is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 November 2019 (7+ years old) and is registered under CIN U24304DL2019PTC357787.
Nicety Pharmaceutical has 2 current directors:
- Shashank - Director
- Rajesh Kumar Singh - Director
The latest financial statements of Nicety Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Nicety Pharmaceutical is 10AAGCN7639F1ZL, registered in Bihar.
The CIN (Corporate Identification Number) of Nicety Pharmaceutical is U24304DL2019PTC357787. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nicety Pharmaceutical was incorporated on 20 November 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Nicety Pharmaceutical by revenue are Kmcure Pharmaceuticals Private Limited, Namokar Vintrade Private Limited, Phlagon Industries Private Limited, Satyabhog Industries (OPC) Private Limited, Pollen Tea Plantation Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Navnitkumar Ramdevnarayan Sinha ceased to be Director on 28 Sep 2023. Rajesh Kumar Singh was appointed as Director on 20 Nov 2019. Shashank was appointed as Director on 20 Nov 2019.
The registered office of Nicety Pharmaceutical is at Plot No – B 7841 Floor Ground Land Mark Near Vaishno Devi Mandir Inder Enclave, New Delhi, Delhi, India – 110081.
Nicety Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Nicety Pharmaceutical can be reached at its registered office: Plot No – B 7841 Floor Ground Land Mark Near Vaishno Devi Mandir Inder Enclave, New Delhi, Delhi, India – 110081.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
